Understanding Type 2 Diabetes: Pathophysiology and Mechanisms

Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by hyperglycemia due to insulin resistance and relative insulin deficiency.

Core Pathophysiology

  1. Insulin resistance: Muscle, liver, adipose tissue fail to respond normally to insulin → impaired glucose uptake, unrestrained hepatic gluconeogenesis.
  2. β-cell dysfunction: Pancreatic β-cells cannot compensate with sufficient insulin secretion; progressive decline.
  3. Increased hepatic glucose output: Liver overproduces glucose due to insulin resistance and glucagon excess.

Contributing Factors

  • Genetics: >400 loci identified; family history doubles risk.
  • Obesity (especially visceral): Adipose inflammation (TNF-α, IL-6) → serine phosphorylation of IRS-1 → insulin signaling blockade.
  • Physical inactivity: Reduces GLUT4 translocation, mitochondrial capacity.
  • Medications: Glucocorticoids, antipsychotics, thiazides, statins (modest).
  • Aging, ethnicity, intrauterine environment.

Clinical Consequence

Chronic hyperglycemia → microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (CVD, stroke, PAD) complications.

Management Pillars

  • Lifestyle (diet, exercise, weight loss).
  • Metformin first-line (improves hepatic insulin sensitivity).
  • Add-ons: SGLT2i, GLP-1 RA, DPP-4i, insulin, TZDs per guidelines.
  • Cardiovascular risk reduction (statin, BP control, ASA if indicated).

Diabetes - Related Articles